News

May 17th, 2019

Presentation will cover the benefits, challenges and industry obstacles to gathering real-world evidence using wearable sensors in clinical trials

April 16th, 2019

NeuroLynQ uses GSR to assess an audience’s nonconscious emotional response; this new release includes additional analytical capabilities

April 10th, 2019

Integrating wearable sensors into clinical trials has become a major point of emphasis for the pharmaceutical industry as it tries to address the rising costs of drug development

March 12th, 2019

Dr. Paolo Bonato, director of the Motion Analysis Laboratory at Spaulding Rehabilitation Hospital in Boston, will use Verisense to monitor motor recovery in stroke survivors

March 05th, 2019

This upcoming performance and experiment will study the audience’s emotional response to Lifesongs

February 13th, 2019

Shimmer Launches Verisense™ Wearable Sensor Platform for Clinical Trials

February 07th, 2019

Ipsos Uses Shimmer’s NeuroLynQ Platform to Conduct the First All-Wireless Neuromarketing Super Bowl Ad Study

January 17th, 2019

You Can Now Measure High G motion force, up to 200g with Shimmer.

November 15th, 2018

NeuroLynQ Wins Best New Wearable Technology Device at IDTechEx annual conference in Santa Clara

November 13th, 2018

Shimmer Research announced that it monitored the psychological arousal of 90 people simultaneously, and in real time, using its NeuroLynQ Platform